Monday, 12 October 2015 - Berlin, Courtyard Berlin City Center
2015 marks the 5th Epidemiological Forum, a growing event that represents the aim to spread knowledge on clinical observational research that has become an essential tool for the development and spread of new health technologies, particularly in the pharmaceutical field. This year the all-day event will be held in Berlin, Monday 12th October.
In 2014, the 4th Epidemiological Forum in Milan focused on the use of epidemiological methods in providing real world evidence to document product value in pre and post marketing activities, and the 5th will focus on:
• Methodological aspects of observational studies
• Regulatory aspects in the European setting
• Case studies and real world examples
In 2015 we may well see pilot regulatory programs of Adaptive Licensing initiated by the EMEA, and value-based pricing programs have expanded internationally to support efficacy-based pricing linked to outcomes and requiring real world data. Furthermore, the pharmaceutical industry has for the most part focused on reimbursement and pharmacogivilance as key drivers for real world evidence generation, but the market overall is moving to outcomes, with quality versus quantity of service provision. As we move to a personalized medicine healthcare system, enabled by new technologies, business models and biological insights, this will only accelerate the need for real world data, evidence and insights.
We are looking forward to stimulating and topical event that addresses key topics and challenges for the field in progressing the legitimacy of observational research in healthcare.
This event aims to bring together experts not only from the world of clinical research but also from academia, public institutions and industry to exchange views and experiences among all the participants, providing networking opportunities and adequate discussion between speakers and audience.
The event is addressed to professionals with a deep interest in drug development and healthcare decision making such as:
Medical Directors, Managing Directors, Medical Affairs Directors, Medical Informatics, R&D Managers, Pharmacovigilance Managers, Clinical Operation Managers, Clinical Research Associates, Clinical Project Managers/Clinical Project Leaders, Statisticians, Data Managers and Data Scientists
from Pharmaceutical and Biotechnology companies, Universities/Hospitals, Academic Research, Patient Associations, Healthcare Organizations and CROs.
Dorothee Bartels, Vice president, Head of Corporate Department Global Epidemiology at Boehringer Ingelheim, Germany
Nigel Hughes, Director Integrative Healthcare Informatics at Janssen Research and Development, Belgium
Stefano Viaggi, Director of Marketing and Real World Data Solutions at MediNeos Observational Research, Italy